28 related articles for article (PubMed ID: 29735021)
21. Application of lipidomics to assess lipogenesis in drug development and pre-clinical trials.
Lamaziere A; Wolf C; Quinn PJ
Curr Pharm Biotechnol; 2012 Apr; 13(5):736-45. PubMed ID: 22122482
[TBL] [Abstract][Full Text] [Related]
22. Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and Δ6- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trial.
Pranger IG; van Raalte DH; Brands M; Muskiet MHA; Kema IP; Serlie MJ; Diamant M; Bakker SJL; Muskiet FAJ
Prostaglandins Leukot Essent Fatty Acids; 2018 May; 132():8-15. PubMed ID: 29735021
[TBL] [Abstract][Full Text] [Related]
23. [Stearoyl-CoA desaturase in the control of metabolic homeostasis].
Dobrzyń P
Postepy Biochem; 2012; 58(2):166-74. PubMed ID: 23214140
[TBL] [Abstract][Full Text] [Related]
24. Recent insights into the relation of Δ5 desaturase and Δ6 desaturase activity to the development of type 2 diabetes.
Kröger J; Schulze MB
Curr Opin Lipidol; 2012 Feb; 23(1):4-10. PubMed ID: 22123669
[TBL] [Abstract][Full Text] [Related]
25. Role of hepatic desaturases in obesity-related metabolic disorders.
Bjermo H; Risérus U
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):703-8. PubMed ID: 20823776
[TBL] [Abstract][Full Text] [Related]
26. The role of Stearoyl-CoA desaturase in hepatic de novo lipogenesis.
Ntambi JM
Biochem Biophys Res Commun; 2022 Dec; 633():81-83. PubMed ID: 36344170
[TBL] [Abstract][Full Text] [Related]
27. Role of de novo lipogenesis in insulin resistance in first-episode psychosis and therapeutic options.
Khan MM
Neurosci Biobehav Rev; 2022 Dec; 143():104919. PubMed ID: 36270454
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
